Germany
Japan
United Kingdom
China
USD 1,890.00
9 Weeks
Lenti ORF particles, NCOA3 (Myc-DDK-tagged)-Human nuclear receptor coactivator 3 (NCOA3), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
cDNA Clones
DownloadUSD 1,890.00
9 Weeks
Lenti ORF particles, NCOA3 (Myc-DDK-tagged)-Human nuclear receptor coactivator 3 (NCOA3), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, SRSF10 (Myc-DDK-tagged)-Human serine/arginine-rich splicing factor 10 (SRSF10), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, SRSF10 (Myc-DDK-tagged)-Human serine/arginine-rich splicing factor 10 (SRSF10), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, YAF2 (Myc-DDK-tagged)-Human YY1 associated factor 2 (YAF2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, SMAD7 (Myc-DDK-tagged)-Human SMAD family member 7 (SMAD7), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, SRSF10 (Myc-DDK-tagged)-Human serine/arginine-rich splicing factor 10 (SRSF10), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IRF3 (Myc-DDK-tagged)-Human interferon regulatory factor 3 (IRF3), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, WT1 (Myc-DDK-tagged)-Human Wilms tumor 1 (WT1), transcript variant E, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SIRT6 (Myc-DDK-tagged)-Human sirtuin 6 (SIRT6), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CTCF (Myc-DDK-tagged)-Human CCCTC-binding factor (zinc finger protein) (CTCF), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, SMAD7 (Myc-DDK-tagged)-Human SMAD family member 7 (SMAD7), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, IRF4 (Myc-DDK-tagged)-Human interferon regulatory factor 4 (IRF4), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 870.00
6 Weeks
Lenti ORF particles, THRA (Myc-DDK-tagged)-Human thyroid hormone receptor, alpha (THRA), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IRF3 (Myc-DDK-tagged)-Human interferon regulatory factor 3 (IRF3), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ZFP91 (Myc-DDK-tagged)-Human zinc finger protein 91 homolog (mouse) (ZFP91), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,190.00
7 Weeks
Lenti ORF particles, POU2F1 (Myc-DDK-tagged)-Human POU class 2 homeobox 1 (POU2F1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, NFATC4 (Myc-DDK-tagged)-Human nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 (NFATC4), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
8 Weeks
Lenti ORF particles, DNM2 (Myc-DDK-tagged)-Human dynamin 2 (DNM2), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,590.00
11 Weeks
Lenti ORF particles, STON1 (Myc-DDK-tagged)-Human STON1-GTF2A1L readthrough (STON1-GTF2A1L), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 2,070.00
6 Weeks
Lenti ORF particles, EIF4G3 (Myc-DDK-tagged)-Human eukaryotic translation initiation factor 4 gamma, 3 (EIF4G3), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CAMTA1 (Myc-DDK-tagged)-Human calmodulin binding transcription activator 1 (CAMTA1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, NME2 (Myc-DDK-tagged)-Human non-metastatic cells 2, protein (NM23B) expressed in (NME2), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, YAF2 (Myc-DDK-tagged)-Human YY1 associated factor 2 (YAF2), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, RBM14 (Myc-DDK-tagged)-Human RNA binding motif protein 14 (RBM14), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, RNF103 (Myc-DDK-tagged)-Human ring finger protein 103 (RNF103), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, MLLT10 (Myc-DDK-tagged)-Human myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 (MLLT10), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, YAF2 (Myc-DDK-tagged)-Human YY1 associated factor 2 (YAF2), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IRF3 (Myc-DDK-tagged)-Human interferon regulatory factor 3 (IRF3), transcript variant 7, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, RBM14 (Myc-DDK-tagged)-Human RNA binding motif protein 14 (RBM14), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, SRSF10 (Myc-DDK tagged) - Human serine/arginine-rich splicing factor 10 (SRSF10), transcript variant 6, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, MLLT10 (Myc-DDK-tagged)-Human myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 (MLLT10), transcript variant 6, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, DDIT3 (Myc-DDK tagged) - Human DNA-damage-inducible transcript 3 (DDIT3), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SIRT2 (Myc-DDK-tagged)-Human sirtuin 2 (SIRT2), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, SMAD7 (Myc-DDK-tagged)-Human SMAD family member 7 (SMAD7), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, VAMP7 (Myc-DDK-tagged)-Human vesicle-associated membrane protein 7 (VAMP7), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, WT1 (Myc-DDK-tagged)-Human Wilms tumor 1 (WT1), transcript variant F, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SIRT5 (Myc-DDK tagged) - Human sirtuin 5 (SIRT5), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IRF3 (Myc-DDK tagged) - Human interferon regulatory factor 3 (IRF3), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, PPIE (Myc-DDK tagged) - Human peptidylprolyl isomerase E (cyclophilin E) (PPIE), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IRF3 (Myc-DDK tagged) - Human interferon regulatory factor 3 (IRF3), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MEF2C (Myc-DDK tagged) - Human myocyte enhancer factor 2C (MEF2C), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TCF7L2 (Myc-DDK-tagged)-Human transcription factor 7-like 2 (T-cell specific, HMG-box) (TCF7L2), transcript variant 12, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MEF2C (Myc-DDK tagged) - Human myocyte enhancer factor 2C (MEF2C), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, GTF2A1L (Myc-DDK-tagged)-Human general transcription factor IIA, 1-like (GTF2A1L), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, NFIB (Myc-DDK tagged) - Human nuclear factor I/B (NFIB), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TCF7L2 (Myc-DDK-tagged)-Human transcription factor 7-like 2 (T-cell specific, HMG-box) (TCF7L2), transcript variant 10, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TCF7L2 (Myc-DDK tagged) - Human transcription factor 7-like 2 (T-cell specific, HMG-box) (TCF7L2), transcript variant 13, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TCF7L2 (Myc-DDK tagged) - Human transcription factor 7-like 2 (T-cell specific, HMG-box) (TCF7L2), transcript variant 7, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MEF2C (Myc-DDK-tagged)-Human myocyte enhancer factor 2C (MEF2C), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Active filters
Category
-
cDNA Clones
- Lentiviral Particles
Species
- Human
Tags
- Myc-DDK
Mutants
- No
Mammalian Cell Selection
- Puromycin
Families
- Transcription Factors
Filter by
Target Symbol
- NRG1 (18)
- CREM (17)
- MORF4L2 (16)
- NR1I3 (15)
- ATXN3 (12)
- TCF7L2 (10)
- PML (9)
- PQBP1 (9)
- PTGER3 (9)
- MITF (8)
- MYB (8)
- PAX3 (8)
- TGIF1 (8)
- ZNF655 (8)
- APBB2 (7)
- CAMKK2 (7)
- ETV1 (7)
- HMGA1 (7)
- IRF5 (7)
- MEIS2 (7)
- MEN1 (7)
- NR3C1 (7)
- PLAGL1 (7)
- RUNX1T1 (7)
- SCMH1 (7)
- SMARCA4 (7)
- STAU2 (7)
- TP53 (7)
- ZBTB20 (7)
- CDK11B (6)
- CNBP (6)
- CNOT4 (6)
- HDAC8 (6)
- ING4 (6)
- IRF3 (6)
- LARP4 (6)
- MAX (6)
- MECOM (6)
- NSD2 (6)
- RBFOX2 (6)
- SF1 (6)
- SRSF10 (6)
- TFDP2 (6)
- TP63 (6)
- WT1 (6)
- ZEB1 (6)
- ZNF200 (6)
- ZNF268 (6)
- DNM2 (5)
- EWSR1 (5)
- GABPB1 (5)
- GTF2I (5)
- HNF4A (5)
- HOPX (5)
- ILF3 (5)
- LRRFIP1 (5)
- MBD1 (5)
- MEF2A (5)
- MEF2C (5)
- MTUS1 (5)
- NCOA4 (5)
- NFAT5 (5)
- NFATC1 (5)
- NFATC4 (5)
- NFYC (5)
- NME2 (5)
- PHTF2 (5)
- PPARD (5)
- PPP2R1B (5)
- RNF14 (5)
- RO60 (5)
- STAT6 (5)
- TCF12 (5)
- TCF7 (5)
- ZFX (5)
- ZNF226 (5)
- ARNT (4)
- ATF3 (4)
- CITED1 (4)
- CREB5 (4)
- EGR2 (4)
- EIF4G3 (4)
- ERG (4)
- ESR1 (4)
- ESRRG (4)
- EYA1 (4)
- GAS7 (4)
- HDAC9 (4)
- HIPK1 (4)
- HNRNPD (4)
- IKBKG (4)
- ING1 (4)
- JDP2 (4)
- KDM4C (4)
- KRBOX4 (4)
- LEF1 (4)
- MAFF (4)
- MDM2 (4)
- MLLT10 (4)
- MSL3 (4)
Lentivirus
Vectors
Pathways
- Pathways in cancer (185)
- Wnt signaling pathway (90)
- MAPK signaling pathway (83)
- Acute myeloid leukemia (68)
- Prostate cancer (68)
- Cell cycle (59)
- Huntington's disease (52)
- Chronic myeloid leukemia (50)
- TGF-beta signaling pathway (50)
- Metabolic pathways (47)
- Thyroid cancer (47)
- Basal transcription factors (45)
- T cell receptor signaling pathway (43)
- Colorectal cancer (42)
- Neurotrophin signaling pathway (41)
- Ubiquitin mediated proteolysis (41)
- B cell receptor signaling pathway (40)
- Small cell lung cancer (40)
- Pancreatic cancer (39)
- Toll-like receptor signaling pathway (39)
- Melanogenesis (38)
- Purine metabolism (37)
- Pyrimidine metabolism (37)
- Basal cell carcinoma (35)
- Cytosolic DNA-sensing pathway (35)
- Endometrial cancer (35)
- Adherens junction (33)
- Adipocytokine signaling pathway (32)
- RNA polymerase (31)
- ErbB signaling pathway (29)
- Apoptosis (28)
- Spliceosome (27)
- Axon guidance (26)
- Maturity onset diabetes of the young (26)
- Natural killer cell mediated cytotoxicity (26)
- Chemokine signaling pathway (25)
- Melanoma (24)
- VEGF signaling pathway (24)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (23)
- Jak-STAT signaling pathway (23)
- RIG-I-like receptor signaling pathway (23)
- Neuroactive ligand-receptor interaction (22)
- Endocytosis (21)
- Renal cell carcinoma (20)
- p53 signaling pathway (20)
- Bladder cancer (18)
- Non-small cell lung cancer (18)
- Oocyte meiosis (18)
- RNA degradation (18)
- Amyotrophic lateral sclerosis (ALS) (17)
- Antigen processing and presentation (17)
- Nucleotide excision repair (17)
- PPAR signaling pathway (17)
- Tight junction (16)
- Glioma (15)
- Insulin signaling pathway (15)
- Notch signaling pathway (15)
- NOD-like receptor signaling pathway (13)
- Viral myocarditis (13)
- Calcium signaling pathway (12)
- Epithelial cell signaling in Helicobacter pylori infection (11)
- Circadian rhythm - mammal (10)
- Systemic lupus erythematosus (10)
- DNA replication (9)
- Focal adhesion (9)
- Lysine degradation (9)
- Primary immunodeficiency (9)
- Alzheimer's disease (8)
- Fc gamma R-mediated phagocytosis (8)
- GnRH signaling pathway (7)
- Long-term depression (7)
- Dorso-ventral axis formation (6)
- Pathogenic Escherichia coli infection (6)
- Allograft rejection (5)
- Base excision repair (5)
- Graft-versus-host disease (5)
- Hedgehog signaling pathway (5)
- Leukocyte transendothelial migration (5)
- Long-term potentiation (5)
- Ribosome (5)
- Type I diabetes mellitus (5)
- Autoimmune thyroid disease (4)
- Cell adhesion molecules (CAMs) (4)
- Cysteine and methionine metabolism (4)
- Cytokine-cytokine receptor interaction (4)
- Fc epsilon RI signaling pathway (4)
- Homologous recombination (4)
- Regulation of actin cytoskeleton (4)
- Type II diabetes mellitus (4)
- Valine (4)
- Aminoacyl-tRNA biosynthesis (3)
- Ether lipid metabolism (3)
- SNARE interactions in vesicular transport (3)
- leucine and isoleucine biosynthesis (3)
- mTOR signaling pathway (3)
- Dilated cardiomyopathy (2)
- Glycerolipid metabolism (2)
- Glycine (2)
- Glyoxylate and dicarboxylate metabolism (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Prion diseases (2)
- serine and threonine metabolism (2)
- Asthma (1)
- Glycolysis / Gluconeogenesis (1)
- Hematopoietic cell lineage (1)
- Mismatch repair (1)
- Nicotinate and nicotinamide metabolism (1)
- Non-homologous end-joining (1)
- Progesterone-mediated oocyte maturation (1)
- Proteasome (1)
- Vascular smooth muscle contraction (1)
- leucine and isoleucine degradation (1)